AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • November 5th, 2020 • Inmune Bio, Inc. • Biological products, (no disgnostic substances)
THIS AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (“Amendment Agreement”) is made and entered into as of October 30, 2020, by and between Inmune Ventures, LLC, a limited liability corporation organized and existing under the laws of the State of Washington, having an office and its principal place of business at 1001 4th Avenue, Suite 4500 Seattle, Washington 98154 (“Licenser”) and INmune Bio, Inc. a corporation organized and existing under the laws of the State of Nevada, having an office and its principal place of business at 1224 Prospect Street, Suite 150, La Jolla, California 92037 (“Licensee”);
